Employee-related Liabilities, Current of LakeShore Biopharma Co., Ltd. from 31 Mar 2022 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD and CNY
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
LakeShore Biopharma Co., Ltd. quarterly Employee-related Liabilities, Current in USD history and change rate from 31 Mar 2022 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Employee-related Liabilities, Current for the quarter ending 31 Mar 2025 was $7,910,037, a 5.4% decline year-over-year.
LakeShore Biopharma Co., Ltd. quarterly Employee-related Liabilities, Current in CNY history and change rate from 31 Mar 2022 to 31 Mar 2025.
  • LakeShore Biopharma Co., Ltd. Employee-related Liabilities, Current for the quarter ending 31 Mar 2025 was ¥56,779,828, a 4.2% decline year-over-year.
Source SEC data
View on sec.gov
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Change (%)
Employee-related Liabilities, Current, Quarterly (CNY)
Employee-related Liabilities, Current, YoY Quarterly Change (%)

LakeShore Biopharma Co., Ltd. Quarterly Employee-related Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $7,910,037 -$447,603 -5.4% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 $8,357,640 +$326,367 +4.1% 31 Mar 2024 20-F 15 Aug 2024 2024 FY
Q1 2023 $8,031,273 31 Mar 2023 20-F 26 Jul 2023 2023 FY

LakeShore Biopharma Co., Ltd. Quarterly Employee-related Liabilities, Current (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 ¥56,779,828 -¥2,517,626 -4.2% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q1 2024 ¥59,297,454 +¥4,108,957 +7.4% 31 Mar 2024 20-F 31 Jul 2025 2025 FY
Q1 2023 ¥55,188,497 -¥2,270,776 -4% 31 Mar 2023 20-F 15 Aug 2024 2024 FY
Q1 2022 ¥57,459,273 31 Mar 2022 20-F 26 Jul 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.